Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Crypto Markets Muted Ahead Of An Eventful Week
  2. Driving Bitcoin's Surge: MicroStrategy Founder on Education, Adoption, and Policy Impact
  3. Bitcoin ($BTC) Price to Rise to $30,000 in Second Half of 2023, VanEck Says
  4. Analyst PlanB On How Current BTC HODLers Will Lay the Foundation for The Next Bitcoin Bull Run
  5. Cryptos Climb Despite A Firm Dollar And Lingering Fed Fears